CureSearch Research Programs: Request for Applications
For more than 30 years, CureSearch has been a driving force in pediatric cancer research. Recognizing a broken system, growing obstacles, and unmet needs in drug development, we’ve launched an innovative and unique strategy to address the urgent, critical need for new childhood cancer treatments. Our success is measured by the rate of a funded project’s progress toward the clinic and marketplace where new treatments can directly impact patients, not by total dollars spent or by publishing in academic journals. We’re focused on results, holding our researchers accountable to rigorous six-month milestones; continued funding is dependent on achieving agreed upon goals
Funding Opportunity Announcement
We anticipate the application window to submit Letters of Intent (LOIs) will open October 2020. Click here to add yourself to our mailing list and be the first to know about new RFAs.
Awards will support promising early-stage research, translational research and/or pediatric cancer phase I and II clinical trials with the highest potential of addressing the unmet needs in pediatric oncology drug development. This may include, but is not limited to, areas such as high-risk, relapsed, or metastatic disease, adolescent and young adult patient populations and/or the use of novel immunotherapy targets or modalities for pediatric cancer treatment.
Funding will be provided for up to three years, contingent on demonstration of satisfactory and timely completion of milestones.
Please email Caitlyn Barrett, PhD, National Director of Research and Programs, with any questions or comments.